396 related articles for article (PubMed ID: 11341365)
1. Inhibition of field stimulation-induced contractions of rabbit vas deferens by muscarinic receptor agonists: selectivity of McN-A-343 for M1 receptors.
Davies RH; Scholes HE; Virdi S; Broadley KJ
J Pharm Pharmacol; 2001 Apr; 53(4):487-96. PubMed ID: 11341365
[TBL] [Abstract][Full Text] [Related]
2. Assessment of selectivity of muscarinic antagonists for M1 and M2 receptors in rabbit isolated vas deferens.
Eltze M
Pharmacology; 1988; 37 Suppl 1():40-7. PubMed ID: 2467317
[TBL] [Abstract][Full Text] [Related]
3. Muscarinic M1 receptor agonist actions of muscarinic receptor agonists in rabbit vas deferens.
Shannon HE; Sawyer BD; Bemis KG; Bymaster FP; Health I; Mitch CH; Ward JS
Eur J Pharmacol; 1993 Feb; 232(1):47-57. PubMed ID: 8458395
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the prejunctional muscarinic receptors mediating inhibition of evoked release of endogenous noradrenaline in rabbit isolated vas deferens.
Grimm U; Fuder H; Moser U; Bümert HG; Mutschler E; Lambrecht G
Naunyn Schmiedebergs Arch Pharmacol; 1994 Jan; 349(1):1-10. PubMed ID: 8139696
[TBL] [Abstract][Full Text] [Related]
5. Muscarinic M1- and M2-receptors mediating opposite effects on neuromuscular transmission in rabbit vas deferens.
Eltze M
Eur J Pharmacol; 1988 Jul; 151(2):205-21. PubMed ID: 2844551
[TBL] [Abstract][Full Text] [Related]
6. Effect of extracellular calcium concentration on potency of muscarinic agonists at M1 and M2 receptors in rabbit vas deferens.
Dörje F; Rettenmayr NM; Mutschler E; Lambrecht G
Eur J Pharmacol; 1991 Oct; 203(3):417-20. PubMed ID: 1723047
[TBL] [Abstract][Full Text] [Related]
7. Muscarinic receptor subtypes in the bisected vas deferens of the rat.
Miranda HF; Duran E; Fernandez E; Pinardi G
Gen Pharmacol; 1995 Mar; 26(2):387-91. PubMed ID: 7590092
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characteristics of indoline derivatives in muscarinic receptor subtypes.
Adachi S; Koike K; Takayanagi I
Pharmacology; 1996 Oct; 53(4):250-8. PubMed ID: 8958564
[TBL] [Abstract][Full Text] [Related]
9. Presynaptic muscarinic receptors mediating inhibition of neurogenic contractions in rabbit vas deferens are of the ganglionic M1-type.
Eltz M; Gmelin G; Wess J; Strohmann C; Tacke R; Mutschler E; Lambrecht G
Eur J Pharmacol; 1988 Dec; 158(3):233-42. PubMed ID: 2472963
[TBL] [Abstract][Full Text] [Related]
10. Telenzepine enantiomers block muscarinic M1-receptors with opposite kinetics.
Eltze M
Eur J Pharmacol; 1990 May; 180(1):161-8. PubMed ID: 2365000
[TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of responses to carbachol and McN-A-343 in the rabbit vas deferens.
Choo LK; Mitchelson F
Clin Exp Pharmacol Physiol; 1990 Sep; 17(9):601-11. PubMed ID: 1703935
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the mechanism for the relaxation of rat duodenum mediated via M1 muscarinic receptors.
Hamrouni AM; Gudka N; Broadley KJ
Auton Autacoid Pharmacol; 2006 Jul; 26(3):275-84. PubMed ID: 16879493
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the muscarinic receptor subtype mediating inhibition of the neurogenic contractions in rabbit isolated vas deferens by a series of polymethylene tetra-amines.
Budriesi R; Cacciaguerra S; Toro RD; Bolognesi ML; Chiarini A; Minarini A; Rosini M; Spampinato S; Tumiatti V; Melchiorre C
Br J Pharmacol; 2001 Mar; 132(5):1009-16. PubMed ID: 11226131
[TBL] [Abstract][Full Text] [Related]
14. Evidence for muscarinic M4 receptors mediating nonadrenergic noncholinergic relaxations in rabbit anococcygeus muscle.
Gross J; Mutschler E; Lambrecht G
Naunyn Schmiedebergs Arch Pharmacol; 1997 Oct; 356(4):505-16. PubMed ID: 9349639
[TBL] [Abstract][Full Text] [Related]
15. Effects of brucine, a plant alkaloid, on M(1) muscarinic receptors and alpha(1)-adrenoceptors in the rabbit vas deferens preparation.
Bradley KN; Rowan EG; Harvey AL
Toxicon; 2001 Apr; 39(4):581-7. PubMed ID: 11024498
[TBL] [Abstract][Full Text] [Related]
16. Prejunctional muscarinic (M1)-receptor interactions on guinea-pig ileum: lack of effect of cisapride.
Schuurkes JA; Van Bergen PJ; Van Nueten JM
Br J Pharmacol; 1988 May; 94(1):228-34. PubMed ID: 2456809
[TBL] [Abstract][Full Text] [Related]
17. Postsynaptic integration of cholinergic and dopaminergic signals on medium-sized GABAergic projection neurons in the neostriatum.
Harsing LG; Zigmond MJ
Brain Res Bull; 1998 Apr; 45(6):607-13. PubMed ID: 9566505
[TBL] [Abstract][Full Text] [Related]
18. Pathways involved in muscarinic M1 and M2 receptor stimulation in rabbit vas deferens.
Eltze M
Eur J Pharmacol; 1994 Sep; 263(1-2):31-7. PubMed ID: 7529712
[TBL] [Abstract][Full Text] [Related]
19. The interaction of McN-A-343 with pirenzepine and other selective muscarine receptor antagonists at a prejunctional muscarine receptor.
Choo LK; Mitchelson F; Vong YM
Naunyn Schmiedebergs Arch Pharmacol; 1985 Feb; 328(4):430-8. PubMed ID: 2581148
[TBL] [Abstract][Full Text] [Related]
20. 4-DAMP analogues reveal heterogeneity of M1 muscarinic receptors.
Micheletti R; Giudici L; Turconi M; Donetti A
Br J Pharmacol; 1990 Jul; 100(3):395-7. PubMed ID: 1697193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
